Ozempic for youth? Childhood obesity care gets an overhaul in Canada

You can use your smart phone to browse stories in the comfort of your hand. Simply browse this site on your smart phone.

Using an RSS Reader you can access most recent stories and other feeds posted on this network.

SNetwork Recent Stories

Ozempic for youth? Childhood obesity care gets an overhaul in Canada – GLOBAL

by tmnationtalk on April 14, 202557 Views

April 14, 2025

For the first time in nearly two decades, Canada has updated its national clinical guideline for childhood and adolescent obesity — and this time, the focus isn’t on numbers on a scale.

Instead, the new approach recommends focusing on quality of life and mental health, and even includes medications like GLP-1s for kids 12 and up when needed.

GLP-1 drugs like Ozempic and Wegovy have been approved by Health Canada for adolescents aged 12 and up who have obesity and who haven’t succeeded in weight loss with diet and exercise alone. However, the medication has not been approved for younger children.

Published Monday in the Canadian Medical Association Journal, the new guidelines, developed with the help of Obesity Canada, make 10 recommendations and nine good practice statements for managing obesity in children.